Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 7 clinical trials
A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects

The purpose of this study is to see if using a combination of other drug classes, like the ones that Kaletra® and Intelence™ belong to, can still help reduce the amount of HIV in your

kaletra
opportunistic infection
hiv-1 rna measurement
HIV Vaccine
hormonal contraception
  • 54 views
  • 08 Nov, 2020
  • 1 location
Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients

Kaletra 400/100 mg taken twice a day (bid) in antiretroviral (ARV)-naïve HIV-infected patients at Week 48 Primary Objectives: - To determine the proportion of patients with HIV

lopinavir/ritonavir
antiretroviral agents
ritonavir
antiviral drugs
kaletra
  • 30 views
  • 07 Nov, 2020
  • 1 location
High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease

The purpose of this study is to evaluate the safety, tolerability and efficacy of higher doses of lopinavir/ritonavir, in combination with other anti-HIV medications when administered as either the capsule or liquid formulations, among patients who have not had full viral suppression despite treatment with 3 classes of HIV medications, …

lopinavir/ritonavir
drug test
ritonavir
protease
kaletra
  • 9 views
  • 07 Nov, 2020
  • 1 location
The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection

Based on data regarding the effect of colchicine on the modulation of immune system and decreasing cytokine release and inflammation the question arises whether colchicine, administered in a relatively low dose, could potentially have an effect on COVID-19 Polymerase chain reaction(PCR) positive patients .

fever
colchicine
dyspnea
PCR test
covid-19
  • 0 views
  • 08 Jan, 2021
  • 2 locations
Rapid Experimental Medicine for COVID-19

COVID-19 is a community acquired pneumonia caused by infection with a novel coronavirus, SARS CoV2 and is a serious condition with high mortality in hospitalised patients, for which there is no currently approved treatment other than supportive care. Urgent investigation of potential treatments for this condition is required. This protocol …

pneumonia
chest x-ray
covid-19
SARS
coronavirus infection
  • 25 views
  • 27 Aug, 2020
  • 1 location
A Long-term Follow-up of the HIV-NAT Cohort

With HIV/AIDS increasingly considered a chronic disease, 24-, or 48-week data from antiretroviral studies are no longer sufficient. Only with long-term follow-up and outcome data will shed some much-needed light on the answers of questions that have stumped us for several years. Data from a large observational cohort of patients …

hiv viral load
antiretroviral therapy
antiretroviral agents
AIDS
  • 2 views
  • 16 Sep, 2020
  • 1 location
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.

The purpose of the Antiretroviral Pregnancy Registry (Registry) is to detect any major teratogenic effect involving any of the Registry drugs when administered to pregnant women. Registration is voluntary and confidential with information obtained from the health care provider. A Registry-assigned identifier allows for follow-up capability. Information on subjects is …

hepatitis
antiretroviral agents
antiretrovirals
prenatal
  • 66 views
  • 14 May, 2020
  • 1 location